Published in J Hepatol on April 16, 2007
Association of ghrelin receptor promoter polymorphisms with weight loss following Roux-en-Y gastric bypass surgery. Obes Surg (2012) 1.50
Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet. Am J Physiol Gastrointest Liver Physiol (2011) 1.19
Garlic-derived S-allylmercaptocysteine is a hepato-protective agent in non-alcoholic fatty liver disease in vivo animal model. Eur J Nutr (2012) 1.11
Liver and diabetes. A vicious circle. Hepatol Res (2013) 1.10
Molecular mechanisms of insulin resistance in chronic hepatitis C. World J Gastroenterol (2009) 0.98
Inflammatory mediators and insulin resistance in obesity: role of nuclear receptor signaling in macrophages. Mediators Inflamm (2010) 0.97
Pathophysiology of NASH: perspectives for a targeted treatment. Curr Pharm Des (2013) 0.95
Insulin resistance and inflammation markers in myocardial infarction. J Inflamm Res (2013) 0.93
Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis. Gut (2014) 0.91
Liver fat content in type 2 diabetes: relationship with hepatic perfusion and substrate metabolism. Diabetes (2010) 0.91
Curcumin attenuates the effects of insulin on stimulating hepatic stellate cell activation by interrupting insulin signaling and attenuating oxidative stress. Lab Invest (2009) 0.89
Increased selenoprotein p levels in subjects with visceral obesity and nonalcoholic Fatty liver disease. Diabetes Metab J (2013) 0.89
miR-200s contribute to interleukin-6 (IL-6)-induced insulin resistance in hepatocytes. J Biol Chem (2013) 0.87
Selective hepatic insulin resistance in a murine model heterozygous for a mitochondrial trifunctional protein defect. Hepatology (2013) 0.86
Rapid "breath-print" of liver cirrhosis by proton transfer reaction time-of-flight mass spectrometry. A pilot study. PLoS One (2013) 0.86
Development of nonalcoholic hepatopathy: contributions of oxidative stress and advanced glycation end products. Int J Mol Sci (2013) 0.85
Pivotal role of liver sinusoidal endothelial cells in NAFLD/NASH progression. Lab Invest (2015) 0.84
Non-alcoholic fatty liver disease and fructose: bad for us, better for mice. J Hepatol (2011) 0.83
Relationship between free fatty acids, insulin resistance markers, and oxidized lipoproteins in myocardial infarction and acute left ventricular failure. Diabetes Metab Syndr Obes (2013) 0.83
Carvacrol Protects against Hepatic Steatosis in Mice Fed a High-Fat Diet by Enhancing SIRT1-AMPK Signaling. Evid Based Complement Alternat Med (2013) 0.83
Lipid, adipokine and ghrelin levels in myocardial infarction patients with insulin resistance. BMC Cardiovasc Disord (2014) 0.83
New evidence for the role of ceramide in the development of hepatic insulin resistance. PLoS One (2015) 0.82
Plasminogen activator inhibitor-1, free fatty acids, and insulin resistance in patients with myocardial infarction. Diabetes Metab Syndr Obes (2013) 0.82
White Pitaya (Hylocereus undatus) Juice Attenuates Insulin Resistance and Hepatic Steatosis in Diet-Induced Obese Mice. PLoS One (2016) 0.81
MiR-19a regulates PTEN expression to mediate glycogen synthesis in hepatocytes. Sci Rep (2015) 0.81
Gene Transcriptional and Metabolic Profile Changes in Mimetic Aging Mice Induced by D-Galactose. PLoS One (2015) 0.81
Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling. Nat Commun (2016) 0.81
The effects of either resveratrol or exercise on macrophage infiltration and switching from M1 to M2 in high fat diet mice. J Exerc Nutrition Biochem (2015) 0.81
Long-term exposure to abnormal glucose levels alters drug metabolism pathways and insulin sensitivity in primary human hepatocytes. Sci Rep (2016) 0.81
Mechanisms of Diabetes-Induced Liver Damage: The role of oxidative stress and inflammation. Sultan Qaboos Univ Med J (2016) 0.80
Inhibition of hepatic glycogen synthesis by hyperhomocysteinemia mediated by TRB3. Am J Pathol (2011) 0.80
Lipids promote survival, proliferation, and maintenance of differentiation of rat liver sinusoidal endothelial cells in vitro. Am J Physiol Gastrointest Liver Physiol (2011) 0.80
Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver. Braz J Med Biol Res (2013) 0.79
Angiotensin-induced EGF receptor transactivation inhibits insulin signaling in C9 hepatic cells. Biochem Pharmacol (2009) 0.79
Troglitazone induces cytotoxicity in part by promoting the degradation of peroxisome proliferator-activated receptor γ co-activator-1α protein. Br J Pharmacol (2010) 0.78
Valsartan restores inflammatory response by macrophages in adipose and hepatic tissues of LPS-infused mice. Adipocyte (2013) 0.76
Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies. World J Exp Med (2012) 0.76
Association between hepatitis B virus infection and diabetes mellitus: A meta-analysis. Exp Ther Med (2015) 0.76
Dysregulated hepatic expression of glucose transporters in chronic disease: contribution of semicarbazide-sensitive amine oxidase to hepatic glucose uptake. Am J Physiol Gastrointest Liver Physiol (2014) 0.75
Molecular changes in hepatic metabolism and transport in cirrhosis and their functional importance. World J Gastroenterol (2016) 0.75
IL-10 prevents aging-associated inflammation and insulin resistance in skeletal muscle. FASEB J (2016) 0.75
Hepatic Notch1 deletion predisposes to diabetes and steatosis via glucose-6-phosphatase and perilipin-5 upregulation. Lab Invest (2016) 0.75
Peroxisome Proliferator-Activated Receptor-γGene Expression and Its Association with Oxidative Stress in Patients with Metabolic Syndrome. Chonnam Med J (2016) 0.75
A Different Perspective for Management of Diabetes Mellitus: Controlling Viral Liver Diseases. J Diabetes Res (2017) 0.75
Biochemical markers of type 2 diabetes as a late complication of myocardial infarction: a case-control study. Arch Med Sci (2017) 0.75
Protein phosphatase 4 (PP4) functions as a critical regulator in tumor necrosis factor (TNF)-α-induced hepatic insulin resistance. Sci Rep (2015) 0.75
4-Hydroxyisoleucine improves hepatic insulin resistance by restoring glycogen synthesis in vitro. Int J Clin Exp Med (2015) 0.75
Protective mechanisms of hypothermia in liver surgery and transplantation. Mol Med (2015) 0.75
Hepatitis virus C infection, adipokines and hepatic steato-fibrosis. J Med Life (2010) 0.75
Effect of feeding status on adjuvant arthritis severity, cachexia, and insulin sensitivity in male Lewis rats. Mediators Inflamm (2010) 0.75
Ruscogenin ameliorates experimental nonalcoholic steatohepatitis via suppressing lipogenesis and inflammatory pathway. Biomed Res Int (2014) 0.75
Metabolic syndrome: is equine disease comparable to what we know in humans? Endocr Connect (2014) 0.75
Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis. Dig Dis Sci (2017) 0.75
A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease. Lipids Health Dis (2017) 0.75
Liver progenitor cells yield functional hepatocytes in response to chronic liver injury in mice. Gastroenterology (2012) 3.34
The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology (2009) 2.92
Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells. J Hepatol (2009) 1.89
Chronic administration of valproic acid inhibits activation of mouse hepatic stellate cells in vitro and in vivo. Hepatology (2010) 1.82
Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice. Hepatology (2011) 1.65
Trichostatin A, a histone deacetylase inhibitor, suppresses collagen synthesis and prevents TGF-beta(1)-induced fibrogenesis in skin fibroblasts. Exp Cell Res (2002) 1.36
The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells. J Hepatol (2002) 1.25
Endogenous interleukin-10 modulates fibrosis and regeneration in experimental chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol (2002) 1.20
Neural connections between the hypothalamus and the liver. Anat Rec A Discov Mol Cell Evol Biol (2004) 1.17
Effect of HMG-CoA reductase inhibitors on proliferation and protein synthesis by rat hepatic stellate cells. J Hepatol (2003) 1.14
Differential modulation of rat hepatic stellate phenotype by natural and synthetic retinoids. Hepatology (2004) 1.12
Systemic antigen cross-presented by liver sinusoidal endothelial cells induces liver-specific CD8 T-cell retention and tolerization. Hepatology (2009) 1.07
Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells. Gastroenterology (2003) 1.07
Peroxisome proliferator-activated receptor-beta signaling contributes to enhanced proliferation of hepatic stellate cells. Gastroenterology (2003) 1.03
Successful isolation of liver progenitor cells by aldehyde dehydrogenase activity in naïve mice. Hepatology (2012) 1.02
Vinculin and cellular retinol-binding protein-1 are markers for quiescent and activated hepatic stellate cells in formalin-fixed paraffin embedded human liver. Histochem Cell Biol (2008) 1.01
Actin filament formation, reorganization and migration are impaired in hepatic stellate cells under influence of trichostatin A, a histone deacetylase inhibitor. J Hepatol (2002) 0.98
The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissue. Biochem Pharmacol (2003) 0.96
Blebbistatin inhibits contraction and accelerates migration in mouse hepatic stellate cells. Br J Pharmacol (2009) 0.96
The quest for liver progenitor cells: a practical point of view. J Hepatol (2009) 0.95
Trichostatin A induces differential cell cycle arrests but does not induce apoptosis in primary cultures of mitogen-stimulated rat hepatocytes. J Hepatol (2003) 0.93
On the origin of stellate cells: mesodermal, endodermal or neuro-ectodermal? J Hepatol (2004) 0.92
Regulation of sinusoidal perfusion in portal hypertension. Anat Rec (Hoboken) (2008) 0.90
Role of epigenetics in liver-specific gene transcription, hepatocyte differentiation and stem cell reprogrammation. J Hepatol (2009) 0.90
Distribution of human beta-defensin polymorphisms in various control and cystic fibrosis populations. Genomics (2005) 0.89
Trichostatin a enhances gap junctional intercellular communication in primary cultures of adult rat hepatocytes. Toxicol Sci (2006) 0.89
Somatostatin at nanomolar concentration reduces collagen I and III synthesis by, but not proliferation of activated rat hepatic stellate cells. Br J Pharmacol (2005) 0.87
Multidrug resistance-associated proteins are crucial for the viability of activated rat hepatic stellate cells. Hepatology (2008) 0.81
Influence of somatostatin and octreotide on liver microcirculation in an experimental mouse model of cirrhosis studied by intravital fluorescence microscopy. Liver Int (2008) 0.80
CRBP-I in the renal tubulointerstitial compartment of healthy rats and rats with renal fibrosis. Nephrol Dial Transplant (2008) 0.79
Leptin-mediated reactive oxygen species production does not significantly affect primary mouse hepatocyte functions in vitro. Eur J Gastroenterol Hepatol (2012) 0.78
Distinct roles for non-muscle myosin II isoforms in mouse hepatic stellate cells. J Hepatol (2010) 0.78
Nerves in liver: superfluous structures? A special issue of The Anatomical Record updating our views on hepatic innervation. Anat Rec B New Anat (2005) 0.77
P311 modulates hepatic stellate cells migration. Liver Int (2014) 0.77
Screening of amide analogues of Trichostatin A in cultures of primary rat hepatocytes: search for potent and safe HDAC inhibitors. Invest New Drugs (2008) 0.76
Stellate cells in the digestive tract. Curr Gastroenterol Rep (2003) 0.75
Expression of somatostatin receptors in splanchnic blood vessels of normal and cirrhotic rats. Liver Int (2007) 0.75
Insulin-like growth factor (IGF)-I binding to a cell membrane associated IGF binding protein-3 acid-labile subunit complex in human anterior pituitary gland. J Neurochem (2002) 0.75